KIDRON MIRIAM (Chief Scientific Officer) reported 1 transaction at ORAMED PHARMACEUTICALS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/31/2026ACC: 0001213900-26-037446
DirectorOfficer· Chief Scientific Officer
Since Feb 2019
-435.08K
Net shares
Net seller
$1.44M
Total sold
0
Open market trades
0B · 0S
1
Total transactions
435.08K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−435.08K
Price / share
$3.31
Trade value
$1.44M
% of position
27.7%
3/30/2026
1.57M→1.13M
Total
Net shares
−435.08K
Net value
-$1.44M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/30/2026 | F · Tax Withholding | −435.08K | $3.31 | $1.44M | 27.7% | 1.57M | 1.13M |
| Total | −435.08K | -$1.44M | ||||||
Derivative Transactions0
No derivative transactions reported